SPON2 and benign prostatic hyperplasia: Subsequent analysis of clinical samples showed that the level of SPON2 is significantly higher in patients with PC than healthy controls, both at the level of tissue (n = 44 PC, n = 19 BPH, n = 10 normal prostate tissue) and serum (n = 70 PC, n = 13 healthy donors).